aTyr Pharma ATYR Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about aTyr Pharma's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is aTyr Pharma's other income (expense)?
- aTyr Pharma (ATYR) reported other income (expense) of $644K in Q1 2026.
- How has aTyr Pharma's other income (expense) changed year-over-year?
- aTyr Pharma's other income (expense) decreased by 27.8% year-over-year, from $892K to $644K.
- What is the long-term trend for aTyr Pharma's other income (expense)?
- Over 4 years (2021 to 2025), aTyr Pharma's other income (expense) has grown at a 95.9% compound annual growth rate (CAGR), from $238K to $3.5M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.